Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25978259 | 0.84 | ALDH1A1 (0.39) | MEN1KMT2A | |
| SCHEMBL25532220 | 0.72 | MEN1 (0.35) | MEN1KMT2A | |
| SCHEMBL21084979 | 0.68 | MEN1 (0.35) | MEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL8736714 | 0.66 | MEN1 (0.39) | MEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL8618138 | 0.66 | MEN1 (0.44) | MEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL9369077 | 0.66 | MEN1 (0.38) | MEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL27363694 | 0.65 | MEN1 (0.38) | MEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL21989948 | 0.62 | MEN1 (0.44) | MEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL21793207 | 0.61 | ALDH1A1 (0.36) | MEN1KMT2A | |
| SCHEMBL22790729 | 0.60 | MEN1 (0.32) | MEN1CYP3A4ALOX15KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230250091-A1 | ASGPR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES | LYCIA THERAPEUTICS, INC. | 2023-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230250091-A1 | ASGPR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES | ASGR1, LAMP2, FCGR2A | MEN1 4092/4885CYP3A4 4106/4885ALOX15 3089/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.